MENU
+Compare
CURE
ETF ticker: NYSE ARCA
AS OF
Jul 25 closing price
Price
$80.53
Change
+$1.08 (+1.36%)
Net Assets
157.08M

CURE Direxion Daily Healthcare Bull 3X ETF Forecast, Technical & Fundamental Analysis

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index... Show more

Category: #Trading
CURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CURE with price predictions
Jul 25, 2025

CURE in -3.59% downward trend, sliding for three consecutive days on July 21, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CURE declined for three days, in of 300 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for CURE crossed bearishly below the 50-day moving average on July 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on CURE as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CURE just turned positive on July 24, 2025. Looking at past instances where CURE's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

CURE moved above its 50-day moving average on July 23, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CURE advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

CURE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 257 cases where CURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

View a ticker or compare two or three
CURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TVRCX15.560.07
+0.45%
NAA Allocation C
PLJMX58.380.26
+0.45%
Putnam Research R6
RYHEX109.280.47
+0.43%
Rydex Health Care A
MSXAX68.240.27
+0.40%
NYLI S&P 500 Index Class A
MITCX34.990.13
+0.37%
MFS Massachusetts Investors Tr C

CURE and ETFs

Correlation & Price change

A.I.dvisor indicates that over the last year, CURE has been loosely correlated with SSO. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CURE jumps, then SSO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURE
1D Price
Change %
CURE100%
+1.36%
SSO - CURE
61%
Loosely correlated
+0.75%
SPXL - CURE
59%
Loosely correlated
+1.11%
QLD - CURE
41%
Loosely correlated
+0.40%
TQQQ - CURE
40%
Loosely correlated
+0.57%
QULL - CURE
31%
Poorly correlated
N/A
More